| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/1999 | WO1998048009A3 Materials and methods for ribozyme treatment of retinal diseases |
| 03/25/1999 | WO1998042296A3 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 03/25/1999 | DE19741607A1 New polypeptides comprising prion protein sequences |
| 03/25/1999 | CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas |
| 03/25/1999 | CA2304982A1 Sense mrna therapy |
| 03/25/1999 | CA2304368A1 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
| 03/25/1999 | CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 03/25/1999 | CA2304309A1 Dna encoding a ras carboxyl-terminal processing protein |
| 03/25/1999 | CA2304208A1 Intrabody-mediated control of immune reactions |
| 03/25/1999 | CA2304205A1 Prevention of pregnancy miscarriages |
| 03/25/1999 | CA2304167A1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 03/25/1999 | CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 03/25/1999 | CA2304124A1 Bci-2-like protein bim and methods of use thereof |
| 03/25/1999 | CA2304095A1 Treatment of vascular graft implants with g-csf |
| 03/25/1999 | CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 03/25/1999 | CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/1999 | CA2303397A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections |
| 03/25/1999 | CA2303227A1 Human prl-1 phosphatase |
| 03/25/1999 | CA2303225A1 Dna30942 polypeptide, a tnfr homolog |
| 03/25/1999 | CA2303002A1 Mammalian genes participating in circadian period |
| 03/25/1999 | CA2302834A1 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c |
| 03/25/1999 | CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/25/1999 | CA2296045A1 Persephin and related growth factors |
| 03/25/1999 | CA2271447A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 03/25/1999 | CA2244978A1 Novel alcohol dehydrogenase |
| 03/25/1999 | CA2244971A1 Mure |
| 03/25/1999 | CA2244967A1 Murf |
| 03/25/1999 | CA2244954A1 Murf |
| 03/24/1999 | EP0903409A2 Aminopeptidase (AmpS) |
| 03/24/1999 | EP0903408A2 Tat-derived transport polypeptide |
| 03/24/1999 | EP0903407A2 Streptococcus pneumoniae phoH gene |
| 03/24/1999 | EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them |
| 03/24/1999 | EP0903150A1 Regulation of immunoglobulin production by interleukin-9 |
| 03/24/1999 | EP0903149A1 Method of screening apoptosis inducing substances |
| 03/24/1999 | EP0903148A2 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 03/24/1999 | EP0903147A2 Use of REG-2 as a Schwann cell mitogen |
| 03/24/1999 | EP0903143A2 Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels |
| 03/24/1999 | EP0902837A1 Tailless nuclear hormone receptor (tlx receptor) |
| 03/24/1999 | EP0902836A1 Asymmetric hammerhead ribozymes |
| 03/24/1999 | EP0902791A1 Extracellular/epidermal growth factor hcaba58x |
| 03/24/1999 | EP0902780A1 Quaternary cytofectins |
| 03/24/1999 | EP0902624A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 03/24/1999 | EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 03/24/1999 | EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 03/24/1999 | EP0679079B1 Solution containing igf-1 |
| 03/24/1999 | EP0673199B1 Stabilized lanthionine bacteriocin compositions |
| 03/24/1999 | EP0664786B1 Arginine keto-amide enzyme inhibitors |
| 03/24/1999 | EP0589995B1 Novel polypeptides and their use |
| 03/24/1999 | EP0534978B1 Interleukin-1 antagonist and uses thereof |
| 03/24/1999 | CN1212017A Hybrid proteins which form heterodimers |
| 03/24/1999 | CN1212016A Recombinant ribonuclease proteins |
| 03/24/1999 | CN1212013A Method of purifying thrombin-like protease enzymes obtained from snake venom |
| 03/24/1999 | CN1211991A Compounds with growth hormone releasing properties |
| 03/24/1999 | CN1211990A Isoquinolines useful as analgesics |
| 03/24/1999 | CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 03/24/1999 | CN1211924A Immunomodulatory complex for helicobacter bacteria |
| 03/24/1999 | CN1211918A TNF－α转变酶 TNF-α converting enzyme |
| 03/24/1999 | CN1211578A PEG-inerferon conjugates |
| 03/24/1999 | CN1211448A 双酵胶囊 Dual yeast capsules |
| 03/23/1999 | US5886179 Nucleotide analogs |
| 03/23/1999 | US5886163 A recombinant nucleic acid molecule which encodes a mutant hiv-1 gp120 envelope glycoprotein comprising a v3 loop deletion and a c4 domains.sub.(w.fwdarw.x) point mutation, wherein x is an amino acid residue other than tryptophan |
| 03/23/1999 | US5886156 A complex of tri or teterapeptide covalently linked to the peptide either directly or through a linker and lipid or mixture of lipids; useful in treatment of respiratory distress syndrome |
| 03/23/1999 | US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering |
| 03/23/1999 | US5886151 An isolated and purified dna molecule encoding candida albicans protein with integrin-like motifs; for use in vaccines |
| 03/23/1999 | US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 03/23/1999 | US5886149 P53 response genes |
| 03/23/1999 | US5886147 Compounds useful for the synthesis of dolastatin analogs |
| 03/23/1999 | US5886146 Inhibitors of thrombosis |
| 03/23/1999 | US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof |
| 03/23/1999 | US5886141 Smooth muscle mitogen peptides and DNA coding therefor |
| 03/23/1999 | US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute |
| 03/23/1999 | US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins |
| 03/23/1999 | US5886036 Treating hiv infections |
| 03/23/1999 | US5886026 Anti-angiogenic compositions and methods of use |
| 03/23/1999 | US5885974 Decreases the dosage of bioactive agent necessary, when administered to a patient with abnormal cell metabolism, to correct the abnormal cell metabolism and promote the resumption of normal cell metabolism |
| 03/23/1999 | US5885971 Gene therapy by secretory gland expression |
| 03/23/1999 | US5885970 Antisense oligonucleotides against human protein kinase C |
| 03/23/1999 | US5885967 Anticoagulants |
| 03/23/1999 | US5885965 Synthetic human salivary proteins as fungicides or bactericides, treating infections |
| 03/23/1999 | US5885964 Administering to the patient suffering from osteoporosis an effective amount of an agent comprising kininogen or kininogen peptide to prevent bone resorption |
| 03/23/1999 | US5885962 Stem cell factor analog compositions and method |
| 03/23/1999 | US5885961 Methods of using epithelins to modulate cell proliferation |
| 03/23/1999 | US5885960 Method of treatment comprising administering a combination comprising FGF and polyelectrolytes |
| 03/23/1999 | US5885959 Cyclic peptide compounds and their production process |
| 03/23/1999 | US5885958 Mu (morphine) opiate receptor; used in pharmaceuticals for providing analesia, treatment of gastrointestinal disorders, and therapy for drug dependence |
| 03/23/1999 | US5885957 Treatment of HTLV-I infections |
| 03/23/1999 | US5885956 Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand |
| 03/23/1999 | US5885836 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 03/23/1999 | US5885834 Inducing apoptosis in cell by identifying phosphodiesterase pde1b1 in cell line comprising said cancer cell, synthesizing antisense oligodeoxynucleotide asodn inhibitor to bind to mrna coding pde1b1, applying asodn to cell to induce apoptosis |
| 03/23/1999 | US5885833 Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs |
| 03/23/1999 | US5885831 A protein encoded by drosophila timeless gene; a kit useful for diagnosis and treatment of disorders related to sleep wake cycle |
| 03/23/1999 | US5885811 Leader sequence inducing a post-translational modification of polypeptides in bacteria gene therefor and subtilin variant of enhanced stability and activity |
| 03/23/1999 | US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting |
| 03/23/1999 | US5885805 gbpA |
| 03/23/1999 | US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid |
| 03/23/1999 | US5885803 Disease associated protein kinases |
| 03/23/1999 | US5885800 DNA encoding tumor necrosis related receptor, TR4 |
| 03/23/1999 | US5885799 Hepatitis C virus protease |
| 03/23/1999 | US5885798 Isolated polynucleotide sequence encoding the polypeptide comprising the given amino acid sequence |
| 03/23/1999 | US5885796 CTLA4 receptor and uses thereof |